Clinical trials
Intestinal Diseases trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
83 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2011 | 5 |
| 2012 | 1 |
| 2013 | 4 |
| 2014 | 1 |
| 2015 | 5 |
| 2016 | 8 |
| 2017 | 5 |
| 2018 | 4 |
| 2019 | 7 |
| 2020 | 2 |
| 2021 | 5 |
| 2022 | 5 |
| 2023 | 7 |
| 2024 | 8 |
| 2025 | 5 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 52 |
| Recruiting | 13 |
| Unknown status | 6 |
| Enrolling by invitation | 5 |
| Not yet recruiting | 4 |
| Terminated | 2 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Washington University School of Medicine | 3 |
| Wellspect HealthCare | 3 |
| Boston Children's Hospital | 2 |
| Capso Vision, Inc. | 2 |
| Fenerbahce University | 2 |
| Medtronic - MITG | 2 |
| Northwestern University | 2 |
| Odense University Hospital | 2 |
| Société des Produits Nestlé (SPN) | 2 |
| University of British Columbia | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Intestinal Diseases | 83 |
| Gastrointestinal Diseases | 14 |
| Digestive System Diseases | 12 |
| Inflammatory Bowel Diseases | 10 |
| Colonic Diseases | 8 |
| Colitis, Ulcerative | 7 |
| Crohn Disease | 7 |
| Spinal Cord Injuries | 6 |
| Rectal Neoplasms | 5 |
| Celiac Disease | 4 |
Trials
Showing 76 to 83 of 83. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.